MIRATI THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at MIRATI THERAPEUTICS is $150,000, based on 38 certified filings from FY 2020 to FY 2024. This is 25% higher than the national H-1B median salary of $120,000. Compensation at MIRATI THERAPEUTICS reflects their market positioning, with entry-level roles starting around $125,000 and senior positions reaching $188,843 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at MIRATI THERAPEUTICS range from $86,299 at the 10th percentile to $188,843 at the 90th percentile, showing a $102,544 spread across experience levels and roles. The 25th percentile is $125,000 and the 75th percentile is $164,000.

Yes, MIRATI THERAPEUTICS actively sponsors H-1B visas in FY 2024. In the most recent fiscal year (FY 2024), MIRATI THERAPEUTICS filed 8 H-1B labor condition applications with 8 certified and 0 denied, at a median salary of $162,474. Across FY 2020–2024, they have filed 42 total H-1B applications with 38 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. MIRATI THERAPEUTICS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2024), MIRATI THERAPEUTICS filed 8 H-1B applications, with 8 certified and 0 denied. Over 5 years of data, MIRATI THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

MIRATI THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 42 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating MIRATI THERAPEUTICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating MIRATI THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

MIRATI THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 38 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles MIRATI THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at MIRATI THERAPEUTICS:

The most frequently sponsored role is Senior Research Scientist with 8 filings at a median salary of $130,000. This is followed by Principal Clinical Data Manager (6 filings) and Research Scientist.

MIRATI THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where MIRATI THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top MIRATI THERAPEUTICS H-1B locations:

The largest H-1B hub for MIRATI THERAPEUTICS is San Diego, CA with 36 filings at a median salary of $152,250. The highest-paying location is San Diego, CA at $152,250 median. Salaries range from $134,000 to $152,250 across office locations.

MIRATI THERAPEUTICS's median H-1B salary has increased by +88% from FY 2020 ($86,299) to FY 2024 ($162,474). Tracking salary trends over time reveals how MIRATI THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at MIRATI THERAPEUTICS.

Year-by-year breakdown:

• FY 2020: $86,299 (4 certified)
• FY 2021: $155,000 (8 certified)
• FY 2022: $134,000 (13 certified)
• FY 2023: $164,274 (5 certified)
• FY 2024: $162,474 (8 certified)

This 88% growth reflects strong compensation adjustments at MIRATI THERAPEUTICS, keeping pace with market demands for H-1B talent.

MIRATI THERAPEUTICS primarily files H-1B applications at Wage Level IV, accounting for 74% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making MIRATI THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, MIRATI THERAPEUTICS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

MIRATI THERAPEUTICS's median H-1B salary of $150,000 is 25% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating MIRATI THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare MIRATI THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

This places MIRATI THERAPEUTICS among the higher-paying H-1B sponsors in the industry. Candidates considering H-1B sponsorship should weigh this competitive compensation alongside other factors like role growth, location, and visa processing track record.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. MIRATI THERAPEUTICS's higher proportion of Level III-IV positions (92%) may benefit from wage-based lottery prioritization.

With 38 certified filings, MIRATI THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.